ORIC
NASDAQ
US
Oric Pharmaceuticals, Inc. - Common Stock
$8.89
▲ +$1.42
(+18.93%)
Vol 7.3M
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$796.6M
ROE
-45.3%
D/E
0.00
Beta
1.28
52W
$4–$15
Wall Street Consensus
21 analysts · Apr 20269
Strong Buy
10
Buy
2
Hold
0
Sell
0
Strong Sell
90.5%
Buy Rating
Price Chart
Similar Stocks
CDNA
CareDx Inc
P/E 15.9
$969.0M
INBX
Inhibrx Biosciences Inc
$1.1B
JANX
Janux Therapeutics Inc
$830.0M
MPLT
MapLight Therapeutics Inc
$797.0M
XNCR
Xencor Inc
$1.1B
ABUS
Arbutus Biopharma Corp
$925.1M
CGEM
Cullinan Therapeutics Inc
$611.4M
SANA
Sana Biotechnology Inc
$1.1B
SPRY
ARS Pharmaceuticals Inc
$1.2B
Earnings
Beat rate: 75.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.37 | $-0.30 | +$0.07 |
| Sep 2025 | $-0.41 | $-0.33 | +$0.08 |
| Jun 2025 | $-0.45 | $-0.47 | $-0.02 |
| Mar 2025 | $-0.52 | $-0.42 | +$0.10 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -51.9% | -51.7% | -51.9% | -51.9% | -51.9% | -45.3% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 16.13 | 16.13 | 16.13 | 16.13 | 16.13 | 14.65 |
Key Ratios
ROA (TTM)
-41.8%
P/B
2.3
EPS (TTM)
$-1.73
CF/Share
$-1.96
52W High
$14.93
52W Low
$3.90
$3.90
52-Week Range
$14.93
How does ORIC compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ORIC valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
2.3
▼
5%
below
peers
(2.5)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ORIC profitability vs Biotechnology peers
ROE
-45.3%
▲
33%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-41.8%
▲
11%
above
peers
(-46.7%)
vs Peers
vs Industry
In line
ORIC financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
14.7
▲
230%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.3
▲
32%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
ORIC fundamentals radar
ORIC
Peer median
Industry
ORIC profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ORIC vs peers: key metrics
Latest News
We're 6 Weeks Away From a Historic Change at the Federal Reserve …
Nasdaq · Apr 04
OpenAI just raised a historic amount of money. Here are 2 stunning …
Yahoo Finance · Apr 01
Ripple CEO predicts new timeline for historic crypto legislation
Yahoo Finance · Mar 29
"Historic Injustice": DOJ Settles With Retired Gen. Flynn For Malicious Russiagate Prosecution
ZeroHedge · Mar 26
Chevron Warns California Facing Historic Fuel Crisis As Diesel Hits Record $7
ZeroHedge · Mar 26